Robert Winn, MD | |
12605 E 16th Ave, Aurora, CO 80045-2545 | |
(720) 848-0000 | |
Not Available |
Full Name | Robert Winn |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 12605 E 16th Ave, Aurora, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295825875 | NPI | - | NPPES |
57775702 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 37401 (Colorado) | Primary |
Entity Name | The Board Of Trustees Of The University Of Illinois |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.
Scientific research teams in California and Texas have been awarded nearly $1.4 million in grants to study ways to improve pediatric heart transplant outcomes.
The Senate is expected to refuse to accept the Republican plan to fix the way Medicare pays doctors and that could fray a bipartisan effort to find a long-term solution to the problem.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The rule, which was finalized Friday, will result in an estimated $1.3 billion in rebates for nearly 16 million Americans.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Winn, MD Po Box 876, Aurora, CO 80040-0876 Ph: (303) 493-7000 | Robert Winn, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.
Scientific research teams in California and Texas have been awarded nearly $1.4 million in grants to study ways to improve pediatric heart transplant outcomes.
The Senate is expected to refuse to accept the Republican plan to fix the way Medicare pays doctors and that could fray a bipartisan effort to find a long-term solution to the problem.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The rule, which was finalized Friday, will result in an estimated $1.3 billion in rebates for nearly 16 million Americans.
› Verified 7 days ago
Samiran Bhattacharya, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1635 Aurora Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Payal Rohit Patel, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-6024 | |
Jonathan A Gutman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jeffrey Glasheen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Micol Rothman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Larry Allen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Virginia Borges, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |